Augmedix, Inc. Quarterly Cost of Revenue in USD from Q1 2020 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Augmedix, Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2020 to Q3 2023.
  • Augmedix, Inc. Cost of Revenue for the quarter ending September 30, 2023 was $5.94M, a 38.9% increase year-over-year.
  • Augmedix, Inc. Cost of Revenue for the twelve months ending September 30, 2023 was $21.6M, a 35.7% increase year-over-year.
  • Augmedix, Inc. annual Cost of Revenue for 2022 was $17M, a 39.7% increase from 2021.
  • Augmedix, Inc. annual Cost of Revenue for 2021 was $12.2M, a 25.5% increase from 2020.
  • Augmedix, Inc. annual Cost of Revenue for 2020 was $9.69M, a 2.76% increase from 2019.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $21.6M $5.94M +$1.66M +38.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $19.9M $5.72M +$1.58M +38.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $18.3M $5.24M +$1.37M +35.4% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $17M $4.7M +$1.06M +29.2% Oct 1, 2022 Dec 31, 2022 10-K 2023-04-17
Q3 2022 $15.9M $4.27M +$1.18M +38.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $14.7M $4.13M +$1.37M +49.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $13.4M $3.87M +$1.21M +45.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $12.2M $3.64M +$1.1M +43.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 $11.1M $3.09M +$724K +30.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-18
Q2 2021 $10.3M $2.76M +$566K +25.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $9.76M $2.67M +$74.8K +2.89% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $9.69M $2.54M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $2.37M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $2.2M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $2.59M Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-06-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.